It's the wild wild west out there. There are no clinical outcomes studies available. There is a huge placebo effect. The public is being tricked. And some clinics are making big mistakes.
Some Nebraskans sickened by unapproved stem cell treatments, officials say (Omaha.com) Federal and state health officials on Friday warned of risks associated with unapproved products derived from stem cells, placentas and umbilical cord blood. In an advisory sent to Nebraska health care providers, officials said some people in the state became ill after receiving a product — called exosomes — derived from placentas. The Food and Drug Administration also issued a safety notice Friday alerting patients, health care providers and clinics of “multiple recent reports of serious adverse events experienced by patients in Nebraska who were treated with unapproved products marketed as containing exosomes.” State officials began investigating after learning of the illnesses, said Dr. Maureen Tierney, head of the health care-associated infections program in the Nebraska Department of Health and Human Services, and determined that the therapy was the source. Fewer than five people became ill, ...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

